ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

In Brief: GM Prizes To Withers, Cory, Korsmeyer, Horvitz; Univ. of Chicago, City of Hope Are Comprehensive

May 1, 1998

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

February 15, 2013